The ethical discourse of stakeholders remains ideological and is not consolidated in pharmacy practice. Accelerating market regulation through compliance and effective state action, as well as monetizing pharmaceutical services, could create a more ethical environment for the sector.
Dosea et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: